Exercise Prescription for Patients With Femoral Bone Metastasis: The Added Value of the Computer-Derived Bone Strength Score

Purpose: The BOne Strength (BOS) score is a computed tomography–based quantitative measure that can assist in the prediction of fracture risk in patients with femoral bone metastases. This study explored how the BOS score would impact (1) exercise prescription, (2) confidence in decision-making, and (3) the need to consult a physician before starting the exercise. Methods: Six realistic fictional case vignettes were drafted in pairs with comparable location and size of femur metastasis, Karnofsky Performance Score, and reason for exercise consultation. For each vignette, 10 Dutch physiotherapists were asked which exercises they would advise, their confidence levels on each decision, and whether consultation with a physician was needed before starting the training program. Participants were subsequently provided with high and low BOS scores per pair and answered the questions again. Data were analyzed descriptively. Results: Exercise prescription became more cautious when BOS scores indicated a high fracture risk and less conservative when indicating low fracture risk. Confidence in exercise choice tended to increase in the case of high BOS scores (low risk), but uncertainty remained in the case of low BOS scores (high risk). Finally, the need to consult a physician decreased when the BOS score was available. Conclusions: The BOS score is potentially a clinically relevant tool that could be used when prescribing exercises to patients with increased fracture risk due to femoral bone metastases.

Authors

Institutions

Publication Details

Journal
Rehabilitation Oncology
Published
2026-11-13
DOI
https://doi.org/10.1097/01.reo.0000000000000438
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exercise Prescription for Patients With Femoral Bone Metastasis: The Added Value of the Computer-Derived Bone Strength Score

Florieke Eggermont, Hannah Peters, Stan Overmars, Anne Leppers et al.
Rehabilitation Oncology
Management of metastatic bone disease
article

Exercise Prescription for Patients With Femoral Bone Metastasis: The Added Value of the Computer-Derived Bone Strength Score

Florieke Eggermont, Hannah Peters, Stan Overmars, Anne Leppers, Esther Tanck, Lisan van de Water, Martijn Stuiver, Joris van Asseldonk, Maria de Groot, Mary-Ann Dalzell
article en

Abstract

Purpose: The BOne Strength (BOS) score is a computed tomography–based quantitative measure that can assist in the prediction of fracture risk in patients with femoral bone metastases. This study explored how the BOS score would impact (1) exercise prescription, (2) confidence in decision-making, and (3) the need to consult a physician before starting the exercise. Methods: Six realistic fictional case vignettes were drafted in pairs with comparable location and size of femur metastasis, Karnofsky Performance Score, and reason for exercise consultation. For each vignette, 10 Dutch physiotherapists were asked which exercises they would advise, their confidence levels on each decision, and whether consultation with a physician was needed before starting the training program. Participants were subsequently provided with high and low BOS scores per pair and answered the questions again. Data were analyzed descriptively. Results: Exercise prescription became more cautious when BOS scores indicated a high fracture risk and less conservative when indicating low fracture risk. Confidence in exercise choice tended to increase in the case of high BOS scores (low risk), but uncertainty remained in the case of low BOS scores (high risk). Finally, the need to consult a physician decreased when the BOS score was available. Conclusions: The BOS score is potentially a clinically relevant tool that could be used when prescribing exercises to patients with increased fracture risk due to femoral bone metastases.

Rehabilitation Oncology
Université du Québec à Chicoutimi (CA), University of British Columbia (CA), Radboud University Medical Center (NL), McGill University (CA)
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon